Companies / Belgium
Lilly Closes Belgium R&D Facility, Expands In Ireland
December 2006 | FDI AlertAs part of a restructuring programme for its European operations, US firm Eli Lilly has simultaneously closed its R&D facility in Belgium and announced the construction of biopharmaceutical manufacturing plant in Ireland. BMI believes that the decisions were based on Belgium's worsening business environment and the provision of financial incentives from the Irish government,
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
